Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
复制标题
DOI：
10.3390/pharmacy7030129
复制
发表时间：
2019-09-01
期刊：
影响因子：
2.2
通讯作者：
Minshull, John
中科院分区：
文献类型：
--
作者：
Le Bosquet, Katherine;Barnett, Nina;Minshull, John
开处方是复杂和多因素的，文献中描述了多种方法。在国际上，有指导方针和工具可帮助临床医生和患者识别和安全地撤回不适当的药物，发布共享决策药物优化审查。可用治疗方法的增加和单一疾病模型指南的使用导致了面向处方的医疗保健系统，而取消处方通常被视为一项单独的活动。取消处方应被视为处方的一部分，是确保患者以正确剂量服用最合适药物的关键因素。由于多种药物的复杂性，每个患者的经历和与药物的关系都是独特的。个人的病史必须纳入以患者为中心的药物审查，以便在环境和健康变化的情况下保持药物的最佳效果。法律知识和适当的记录对于确保充分获得同意并根据开始用药时遵循的流程进行记录非常重要。近年来，随着全球感兴趣的临床医生的增加，一些著名的网络已经发展起来，为研究和分享良好实践创造了重要的联系。
Deprescribing is complex and multifactorial with multiple approaches described in the literature. Internationally, there are guidelines and tools available to aid clinicians and patients to identify and safely withdraw inappropriate medications, post a shared decision-making medicines optimisation review. The increase in available treatments and use of single disease model guidelines have led to a healthcare system geared towards prescribing, with deprescribing often seen as a separate activity. Deprescribing should be seen as part of prescribing, and is a key element in ensuring patients remain on the most appropriate medications at the correct doses for them. Due to the complex nature of polypharmacy, every patient experience and relationship with medications is unique. The individual's history must be incorporated into a patient-centred medication review, in order for medicines to remain optimal through changes in circumstance and health. Knowledge of the law and appropriate recording is important to ensure consent is adequately gained and recorded in line with processes followed when initiating a medication. In recent years, with the increase in interested clinicians globally, a number of prominent networks have grown, creating crucial links for both research and sharing of good practice.